NCT01266876View on ClinicalTrials.gov

Study of the Safety and Efficacy of REGN727/SAR236553 in Patients With HeFH Hypercholesterolemia

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Hypercholesterolemia
Interventions
DRUG

Alirocumab

Alirocumab two SC injections in the abdomen only.

DRUG

Placebo

Placebo two SC injections in the abdomen only.

Trial Locations (22)

Unknown

Huntsville

Mission Viejo

Newport Beach

Bridgeport

Jacksonville

Miami

Port Orange

Chicago

Kansas City

Auburn

Biddeford

St Louis

Concord

Durham

Cincinnati

Nashville

Houston

Winnipeg

London

Chicoutimi

Montreal

Saint Foy

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY